# Peraso Inc.: Form 10-Q for the period ended Mar 31, 2016

- Company: [Peraso Inc.](/companies/prso.md) (CIK 890394)
- Form: 10-Q
- Filed: 2016-05-10
- Accepted by EDGAR: May 10, 2016, 17:28 ET
- Period: 2016-03-31
- Accession: 0001104659-16-119798
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/890394/000110465916119798/a16-6551_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890394/000110465916119798/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2016-01-01 to 2016-03-31 | $1.5m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2016-01-01 to 2016-03-31 | $863.0k | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2016-01-01 to 2016-03-31 | $588.0k | us-gaap:GrossProfit |
| Research and development | 3 months, 2016-01-01 to 2016-03-31 | $5.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2016-01-01 to 2016-03-31 | $1.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2016-01-01 to 2016-03-31 | −$6.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2016-01-01 to 2016-03-31 | $33.0k | us-gaap:InterestExpense |
| Income tax | 3 months, 2016-01-01 to 2016-03-31 | $20.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2016-01-01 to 2016-03-31 | −$6.9m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months, 2016-01-01 to 2016-03-31 | −$0.10 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months, 2016-01-01 to 2016-03-31 | −$7.2m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months, 2016-01-01 to 2016-03-31 | $200.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2016-03-31 | $10.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2016-03-31 | $24.1m | us-gaap:AssetsCurrent |
| Total assets | at 2016-03-31 | $49.5m | us-gaap:Assets |
| Current liabilities | at 2016-03-31 | $2.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2016-03-31 | $10.7m | us-gaap:Liabilities |
| Shareholders' equity | at 2016-03-31 | $38.8m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 21,292 characters.

*This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the accompanying condensed consolidated financial statements and notes included in this report. This Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which include, without limitation, statements about the market for our technology, our strategy, competition, expected financial performance and capital raising efforts, all information disclosed under Item 3 of this Part I, and other aspects of our business identified in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission on March 15, 2016 and in other reports that we file from time to time with the Securities and Exchange Commission. Any statements about our business, financial results, financial condition and operations contained in this Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “expects,” “intends,” “plans,” “projects,” or similar expressions are intended to identify forward-looking statements. Our actual results could differ materially from those expressed or implied by these forward-looking statements as a result of various factors, including the risk factors described below in “Company Overview,” “Liquidity and Capital Resources; Changes in Financial Condition,” “Risk Factors” and elsewhere in this report and under Item 1A of our annual report on Form 10-K for the year ended December 31, 2015. We undertake no obligation to update publicly any forward-looking statements for any reason, except as required by law, even as new information becomes available or events occur in the future.*

### Company Overview

Our strategy and primary business objective is to become a fabless semiconductor company focused on the development and sale of integrated circuits, or ICs, for the high-speed networking, communications, storage and data center markets. Our solutions deliver time-to-market, performance, power, area and economic benefits for system original equipment manufacturers, or OEMs. We have developed two families of ICs under the Bandwidth Engine® and LineSpeed™ product names. Bandwidth Engine ICs combine our proprietary 1T-SRAM® high-density embedded memory, integrated macro functions and high-speed serial interface, or SerDes, I/O, with our intelligent access technology and a highly efficient interface protocol. The LineSpeed IC product line, is comprised of non-memory, high-speed SerDes I/O devices with clock data recovery, gearbox and retimer functionality, which convert lanes of data received on line cards or by optical modules into different configurations and/or ensure signal integrity.

Certain SerDes products have been developed under a strategic development and marketing agreement with Credo Semiconductor Ltd., or Credo. As of March 31, 2016, the Company had paid Credo $4.8 million cumulatively for achievement of development milestones, as well as for mask costs and wafer purchases from third-party vendors. All amounts incurred have been recorded as research and development expenses. Currently, under the strategic development and marketing agreement, the Company is entitled to a remaining reimbursement amount of $3.5 million of development costs based on payments made to Credo to date. This amount is subject to increase as additional payments are made to Credo. The reimbursement will be funded by the gross profits earned by the Company from the sale of the relevant SerDes products, with the initial gross profits being primarily applied to reimbursing the Company for these development payments and a portion paid to Credo. Once the full amount has been reimbursed, the gross profits from these products will be shared equally by the Company and Credo.

Historically, our primary business was the design, development, marketing, sale and support of differentiated intellectual property, or IP, including embedded memory and high-speed parallel and SerDes I/O used in advanced systems-on-chips, or SoCs. Currently, we are focused on developing differentiated IP-rich IC products and are dedicating all our research and development, marketing and sales budget to these IC products.

Our future success and ability to achieve and maintain profitability are dependent on the marketing and sales of our IC products into networking, communications and other markets requiring high-bandwidth memory access.

In the first quarter of 2016, we effected a reduction in our workforce and associated operating expenses, net loss and cash burn and to realign resources, as we have substantially concluded development of new products, including our third generation Bandwidth Engine IC product family, and expect to bring these products to market in 2016. We reduced United States headcount by 12 positions and ceased operations at our subsidiary in Hyderabad, India, which had 18 employees. We anticipate that we will fully implement the planned reductions by the end of the second quarter of 2016. As a result of these reductions, we expect to incur total termination charges of up to $0.7 million, including $0.6 million of charges for severance benefits and other one-time termination costs. The remaining charges represent lease obligations, asset impairments and other expenses related to our Indian subsidiary. Substantially all of these charges were realized and resulted in cash expenditures of $0.6 million in the first quarter of 2016. The remaining charges are expected to be substantially paid in the second quarter of 2016. We expect to realize approximately $3.3 million of savings on an annualized basis from the restructuring.

We expect product revenue to increase in 2016 primarily driven by increased Bandwidth Engine 2 IC revenues, as our existing customers commence full production of systems utilizing our ICs. Furthermore, we expect to expand our customer base and increase our cumulative design win count in 2016.

### Sources of Revenue

*Product.* Product revenue is generally recognized at the time of shipment to our customers. An estimated allowance may be recorded, at the time of shipment, for future returns and other charges against revenue consistent with the terms of sale. IC product revenue and costs relating to sales made through distributors with rights of return and stock rotation are deferred until the distributors sell the product to end customers due to our inability to estimate future returns and credits to be issued. At the time of shipment to distributors, an account receivable for the selling price is recorded, as there is a legally enforceable right to receive payment, inventory is relieved, as legal title to the inventory is transferred upon shipment, and the associated deferred margin is recorded as deferred revenues in the condensed consolidated balance sheets. Revenues are recognized upon receiving notification from the distributors that products have been sold to end customers.

*Royalty.* Royalty revenue represents amounts earned under provisions in our memory licensing contracts that require our licensees to report royalties and make payments at a stated rate based on actual units manufactured or sold by licensees for products that include our memory IP. Our license agreements require the licensee to report the manufacture or sale of products that include our technology after the end of the quarter in which the sale or manufacture occurs, and we recognize royalties in the quarter in which we receive the licensee’s report. The timing and level of royalties are difficult to predict. They depend on the licensee’s ability to market, produce and sell products incorporating our technology.

### Critical Accounting Policies and Estimates

The discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make certain estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis we make these estimates based on our historical experience and on assumptions that we consider reasonable under the circumstances. Actual results may differ from these estimates, and reported results could differ under different assumptions or conditions. Our significant accounting policies and estimates are disclosed in Note 1 of the “Notes to Consolidated Financial Statements” in our Annual Report on Form 10-K for the year ended December 31, 2015. As of March 31, 2016, there have been no material changes to our significant accounting policies and estimates.

### Results of Operations

#### Net Revenue.

*(dollar amounts in thousands)*

|  | March 31, 2016 | 2015 | Change 2015 to 2016 |  |
| --- | ---: | ---: | ---: | ---: |
| Product — three months ended | $1,120 | $180 | $940 | 522% |
| Percentage of total net revenue | 77% | 23% |  |  |

Product revenue increased for the three months ended March 31, 2016 compared with the same period of 2015 primarily due to higher shipment volumes of our Bandwidth Engine products.

*(dollar amounts in thousands)*

|  | March 31, 2016 | 2015 | Change 2015 to 2016 |  |
| --- | ---: | ---: | ---: | ---: |
| Royalty and other— three months ended | $331 | $596 | $(265) | (44)% |
| Percentage of total net revenue | 23% | 77% |  |  |

Royalty and other revenue include revenues generated from licensing agreements. Royalty and other revenue decreased primarily due to a decrease in shipment volumes by licensees whose products incorporate our licensed IP.

#### Cost of Net Revenue and Gross Profit.

*(dollar amounts in thousands)*

|  | March 31, 2016 | 2015 | Change 2015 to 2016 |  |
| --- | ---: | ---: | ---: | ---: |
| Cost of net revenue — three months ended | $863 | $237 | $626 | 264% |
| Percentage of total net revenue | 59% | 31% |  |  |

*(dollar amounts in thousands)*

|  | March 31, 2016 | 2015 | Change 2015 to 2016 |  |
| --- | ---: | ---: | ---: | ---: |
| Gross profit — three months ended | $588 | $539 | $49 | 9% |
| Percentage of total net revenue | 41% | 69% |  |  |

Cost of net revenue is primarily comprised of direct and indirect costs related to the sale of IC products.

Cost of net revenue increased for the three months ended March 31, 2016 compared with the same period of 2015 primarily due to higher IC shipment volumes.

Gross profit increased for the three months ended March 31, 2016, compared with the same period of 2015, primarily due to the increase in gross profit from our product sales due to higher shipment volumes and reduced manufacturing costs, partially offset by the decrease in royalty and other revenue which has no corresponding costs.

#### Research and Development.

*(dollar amounts in thousands)*

|  | March 31, 2016 | 2015 | Change 2015 to 2016 |  |
| --- | ---: | ---: | ---: | ---: |
| Research and development — three months ended | $5,232 | $6,893 | $(1,661) | (24)% |
| Percentage of total net revenue | 361% | 888% |  |  |

17

Our research and development expenses include costs related to the development of our IC products and amortization of intangible assets. We expense research and development costs as they are incurred.

The decrease for the three months ended March 31, 2016 compared with the same period in 2015 was primarily due to decreases in personnel costs, stock-based compensation charges and intangible asset amortization.

We expect research and development expenses to decrease in 2016 due to reductions in personnel as a result of our restructuring activity in the first quarter of 2016, as well as reduced new product mask tooling costs and computer-aided design software expenses.

Research and development expenses included stock-based compensation expense of $0.4 million and $1.0 million for the three months ended March 31, 2016 and 2015, respectively.

#### Selling, General and Administrative.

*(dollar amounts in thousands)*

|  | March 31, 2016 | 2015 | Change 2015 to 2016 |  |
| --- | ---: | ---: | ---: | ---: |
| SG&A — three months ended | $1,516 | $1,614 | $(98) | (6)% |
| Percentage of total net revenue | 104% | 208% |  |  |

Selling, general and administrative, or SG&A, expenses consist primarily of personnel and related overhead costs for sales, marketing, finance, human resources and general management.

The decrease for the three months ended March 31, 2016 compared with the same period in 2015 was primarily due to decreases in personnel costs. We expect SG&A expenses to decrease slightly in 2016 as compared with 2015 due to the effects of our restructuring activity in the first quarter of 2016 combined with decreased legal expenses, partially offset by increased commission expense due to expected increases in product revenue.

Selling, general and administrative expenses included stock-based compensation expense of $0.2 million for each of the three month periods ended March 31, 2016 and 2015.

#### Restructuring Charges.

*(dollar amounts in thousands)*

|  | March 31, 2016 | 2015 | Change 2015 to 2016 |  |
| --- | ---: | ---: | ---: | ---: |
| Restructuring charges — three months ended | $676 | $— | $676 | 100% |
| Percentage of total net revenue | 47% | —% |  |  |

In the first quarter of 2016, we recorded $0.7 million in restructuring charges resulting from a reduction in force and the closure of our operations at our Indian subsidiary. See Note 9 in the Notes to Condensed Consolidated Financial Statements.

#### Interest expense and other income, net

*(dollar amounts in thousands)*

|  | March 31, 2016 | 2015 | Change 2015 to 2016 |  |
| --- | ---: | ---: | ---: | ---: |
| Interest expense and other income, net — three months ended | $(9) | $23 | $(32) | (139)% |
| Percentage of total net revenue | 1% | 3% |  |  |

Interest expense and other income, net primarily consisted of interest expense on our senior secured convertible notes partially offset by interest income on our investments as well as foreign currency transaction activity and other non-operating items.

#### Income Tax Provision.

*(dollar amounts in thousands)*

|  | March 31, 2016 | 2015 | Change 2015 to 2016 |  |
| --- | ---: | ---: | ---: | ---: |
| Income tax provision — three months ended | $20 | $20 | $— | —% |
| Percentage of total net revenue | 1% | 3% |  |  |

The provision for the three months ended March 31, 2016 and 2015 was primarily attributable to taxes on earnings of our foreign subsidiaries and branches. We expect our income tax provision to decline in future periods, as we have ceased operations at our Indian subsidiary. We believe that, based on the history of our operating losses and other factors, the weight of available evidence indicates that it is more likely than not that we will not be able to realize the benefit of our net operating losses, which are primarily generated in the United States. Accordingly, a full valuation reserve has been recorded against our net deferred tax assets.

### Liquidity and Capital Resources; Changes in Financial Condition

#### Cash Flows

As of March 31, 2016, we had cash, cash equivalents and short-term investments of $20.9 million and had total working capital of $21.5 million. Our primary capital requirements are to fund working capital, including development of our IC products and any acquisitions that we make that require cash consideration or expenditures.

Net cash used in operating activities was $7.2 million for the first three months of 2016, which primarily resulted from our net loss of $6.9 million and $1.3 million in net reductions in assets and liabilities, partially offset by non-cash charges, including stock-based compensation expense of $0.6 million and depreciation and amortization expenses of $0.3 million. The changes in assets and liabilities primarily related to the timing of payments to vendors.

Net cash used in operating activities was $7.0 million for the first three months of 2015, which primarily resulted from a net loss of $8.0 million and $0.7 million in the reduction in assets and liabilities, partially offset by non-cash charges, including stock-based compensation expense of $1.2 million and depreciation and amortization expenses of $0.4 million. The changes in assets and liabilities primarily related to the timing of the collection of receivables from customers and payments to vendors.

Net cash provided by investing activities was $4.0 million for the first three months of 2016, and included net amounts transferred to cash and cash equivalents from investments of $4.2 million, which did not impact our liquidity, and $0.2 million for purchases of fixed assets.

Net cash used in investing activities was $11.1 million for the first three months of 2015, and included net amounts transferred from cash and cash equivalents to investments of $11.0 million, which did not impact our liquidity, and $0.1 million for purchases of fixed assets.

Our proceeds from financing activities for the first three months of 2016 of $8.1 million consisted primarily of net proceeds received from the issuance of senior secured convertible notes and proceeds from the purchases of common stock under our employee stock purchase plan.

Our proceeds from financing activities for the first three months of 2015 of $22.0 million consisted primarily of net proceeds received from the sale of common stock through a public offering and proceeds from the exercise of stock options and purchases of common stock under our employee stock purchase plan.

Our future liquidity and capital requirements are expected to vary from quarter to quarter, depending on numerous factors, including:

- level of revenue;
- cost, timing and success of technology development efforts;
- inventory levels, timing of product shipments and length of billing and collection cycles;
- fabrication costs, including mask costs, of our ICs, currently under development;
- variations in manufacturing yields, materials costs and other manufacturing risks;
- costs of acquiring other businesses and integrating the acquired operations;
- profitability of our business; and
- whether interest payments on the Notes are paid in cash or, at our election, in kind through the issuance of new Notes with identical terms for the accrued interest.

We expect our cash expenditures to continue to exceed receipts in 2016, as our revenues will not be sufficient to offset our operating expenses, which include significant research and development expenditures for the expansion and fabrication of our IC products. We believe our existing cash, cash equivalents and investments, along with our existing capital and cash generated from operations, if any, to be sufficient to meet our capital requirements for at least the next 12 months. However, there can be no assurance that our capital is sufficient to fund operations until such time as we begin to achieve positive cash flows. We have an effective shelf registration statement under which we could sell additional securities without advance notice. We might decide to raise additional capital, and there can be no assurance that such funding will be available to us on favorable terms, if at all. The failure to raise capital when needed could have a material adverse effect on our business and financial condition.

If we were to raise additional capital through sales of our equity securities, our stockholders would suffer dilution of their equity ownership. If we engage in additional debt financing, we may be further required to accept terms that restrict our ability to incur additional indebtedness, prohibit us from paying dividends, repurchasing our stock or making investments, and force us to maintain specified liquidity or other ratios, any of which could harm our business, operating results and financial condition. If we need additional capital and cannot raise it on acceptable terms, we may not be able to, among other things:

- develop or enhance our products;
- continue to expand our product development and sales and marketing organizations;
- acquire complementary technologies, products or businesses;
- expand operations, in the United States or internationally;
- hire, train and retain employees; or
- respond to competitive pressures or unanticipated working capital requirements.

Our failure to do any of these things could seriously harm our ability to execute our business strategy and may force us to curtail our research and development plans or existing operations.

### Contractual Obligations

The impact that our contractual obligations as of March 31, 2016 are expected to have on our liquidity and cash flow in future periods is as follows (in thousands):

|  | Payment Due by Period Total | Less than 1 year | 1-3 years | 3-5 years | More than 5 years |
| --- | ---: | ---: | ---: | ---: | ---: |
| Operating leases | $3,359 | $791 | $2,248 | $320 | $— |
| Software licenses | 1,356 | 679 | 677 | — | — |
|  | $4,715 | $1,470 | $2,925 | $320 | $— |

As of March 31, 2016, our software licenses primarily related to computer-aided design software.

## Market risk

As filed, 1,019 characters.

Our investment portfolio consists of money market accounts, certificates of deposit, commercial paper, corporate debt, government-sponsored enterprise bonds and municipal bonds. The portfolio dollar-weighted average maturity of these investments is within 12 months. Our primary objective with this investment portfolio is to invest available cash while preserving principal and meeting liquidity needs. No single security should exceed 5% of the portfolio or $2.0 million at the time of purchase. In accordance with our investment policy, we place investments with high credit-quality issuers and limit the amount of credit exposure to any one issuer. These securities, which approximated $19.0 million as of March 31, 2016 and earned an average annual interest rate of approximately 0.4% during the first three months of 2016, are subject to interest rate and credit risks. We do not have any investments denominated in foreign currencies, and, therefore, are not subject to foreign currency risk on such investments.

## Controls and procedures

As filed, 1,277 characters.

*Disclosure Controls and Procedures.* Our management is responsible for establishing and maintaining adequate internal control over our financial reporting. Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934. Based on this evaluation, our management concluded that as of March 31, 2016, our disclosure controls and procedures were effective.

*Changes in Internal Control over Financial Reporting.* During the first quarter of 2016, there was no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 443 characters.

We face many significant risks in our business, some of which are unknown to us and not presently foreseen. These risks could have a material adverse impact on our business, financial condition and results of operations in the future. We have disclosed a number of material risks under Item 1A of our annual report on Form 10-K for the year ended December 31, 2015, which we filed with the Securities and Exchange Commission on March 15, 2016.

Filed May 10, 2016.
Source: SEC EDGAR, the filing index for accession 0001104659-16-119798. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
